Get the Stockscreener App
0.40
14.32%
0.0501
After Hours:
.40
Organovo Holdings Inc stock is traded at $0.40, with a volume of 163.49K.
It is up +14.32% in the last 24 hours and down -13.23% over the past month.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.
See More
Previous Close:
$0.3499
Open:
$0.36
24h Volume:
163.49K
Relative Volume:
1.88
Market Cap:
$6.15M
Revenue:
-
Net Income/Loss:
$-19.09M
P/E Ratio:
-0.1942
EPS:
-2.06
Net Cash Flow:
$-16.92M
1W Performance:
-4.28%
1M Performance:
-13.23%
6M Performance:
-61.54%
1Y Performance:
-67.21%
1-Day Range:
$0.35
$0.4143
1-Week Range:
$0.32
$0.435
52-Week Range:
$0.3154
$1.74
Organovo Holdings Inc Stock (ONVO) Company Profile
Name
Organovo Holdings Inc
Sector
Industry
Phone
858-224-1000
Address
11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA
Compare ONVO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| ONVO | 0.40 | 6.15M | 0 | -19.09M | -16.92M | -2.06 |
| VRTX | 450.97 | 116.14B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 738.00 | 81.10B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 605.92 | 36.23B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 244.89 | 31.59B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 113.13 | 27.12B | 3.30B | -501.07M | 1.03B | 11.54 |
Organovo Holdings Inc Stock (ONVO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-18 | Initiated | H.C. Wainwright | Buy |
| Nov-10-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-25-17 | Initiated | Raymond James | Outperform |
| Aug-11-15 | Downgrade | Cantor Fitzgerald | Buy → Hold |
| Jun-29-15 | Initiated | Jefferies | Buy |
| Jun-29-15 | Initiated | Piper Jaffray | Overweight |
View All
Organovo Holdings Inc Stock (ONVO) Latest News
Organovo expands equity incentive plan following stockholder approval By Investing.com - Investing.com Nigeria
Organovo expands equity incentive plan following stockholder approval - Investing.com
Organovo Holdings Gains Approval for Key Strategic Moves - TipRanks
ONVOOrganovo Holdings Inc. Latest Stock News & Market Updates - StockTitan
Organovo reports positive Phase 2 results for liver drug FXR314 By Investing.com - Investing.com Australia
Organovo reports positive Phase 2 results for liver drug FXR314 - Investing.com India
Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting - The Manila Times
Organovo's FXR314 Shows Significant Liver Fat Reduction in Phase 2 MASH Trial | ONVO Stock News - StockTitan
Human Liver Models Market 2024-2031| Emerging Technologies, - openPR
Organovo stock plunges to 52-week low of $0.35 amid market challenges - Investing.com India
3D Bioprinting Market Projected to Reach $$$ Billion by 2031 with - openPR
Armistice Capital, LLC Increases Stake in Organovo Holdings Inc - GuruFocus.com
Global Organoids Market to Surge Significantly at a CAGR of ~14% by 2030 | DelveInsight - GlobeNewswire Inc.
Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases - The Manila Times
Organovo's FXR314 Drug Trial Data Selected for Major Liver Conference Presentation | ONVO Stock News - StockTitan
3D Printer Market to Grow by USD 30 Billion (2024-2028), Driven by Rising Consumer Demand for Customized Products, AI-Powered Report Highlights Market TransformationTechnavio - The Malaysian Reserve
Is Health Care's Hottest Stock a Mirage? - AOL
Organovo: Fiscal Q2 Earnings Snapshot - San Antonio Express-News
Organovo stock plunges to 52-week low of $0.39 amid market challenges - Investing.com
Organovo (NASDAQ:ONVO) Coverage Initiated by Analysts at StockNews.com - Defense World
Organovo stock plunges to 52-week low of $0.42 amid market challenges - Investing.com Canada
Organovo (NASDAQ:ONVO) Receives New Coverage from Analysts at StockNews.com - Defense World
How Quickly Can Organovo Holdings Generate Revenue? - AOL
Organovo stock hits 52-week low at $0.43 amid market challenges - Investing.com Australia
Organovo stock hits 52-week low at $0.43 amid market challenges By Investing.com - Investing.com South Africa
Organovo Holdings (FRA:4OR1) Peter Lynch Fair Value : €-19.81 (As of Oct. 09, 2024) - GuruFocus.com
3D Bioprinting Technologies Market Outlook 2024-2031: Trends - openPR
Organovo stock plunges to 52-week low of $0.5 amid market challenges - Investing.com Australia
Analyzing Organovo (NASDAQ:ONVO) & Turnstone Biologics (NASDAQ:TSBX) - Defense World
3D Bioprinting Market valued at USD 1.41 billion in 2024 | ExactitudeConsultancy - GlobeNewswire
3D Bioprinting For Regenerative Medicine Market Focusing On - openPR
3D Printing Metals Market is set for a Potential Growth Worldwide: Hoganas, Organovo, Ponoko - Talented India
Human Liver Models Market to Witness Huge Growth by 2031 - openPR
Organovo (NASDAQ:ONVO) Now Covered by Analysts at StockNews.com - Defense World
Organovo Holdings (LTS:0R02) GF Value Rank : 0 (As of Aug. 17, 2024) - GuruFocus.com
Organovo Holdings (LTS:0R02) Price-to-Operating-Cash-Flow : (As of Aug. 17, 2024) - GuruFocus.com
Organovo Holdings (LTS:0R02) Financial Strength : 3 (As of Jun. 2024) - GuruFocus.com
Organovo Holdings (STU:4OR1) Float Percentage Of Total Shar - GuruFocus.com
Organovo Holdings (STU:4OR1) EV-to-Revenue : 49.10 (As of Aug. 16, 2024) - GuruFocus.com
3D Bioprinting Market Giants Spending Is Going To Boom | Envisiontec, Organovo Holdings, Cellink Global - Newstrail
Organovo grants stock options to executive chairman - Investing.com India
Organovo Holdings Grants Stock Options to Executive Chairman - TipRanks
Organovo Holdings, Inc. Forecasted to Post Q2 2025 Earnings of ($0.26) Per Share (NASDAQ:ONVO) - Defense World
3D Printing Metals Market Is Booming Worldwide | Hoganas, Organovo, Ponoko - openPR
Organovo stock hits 52-week low at $0.51 amid market challenges - Investing.com
Understand the 3D Bioprinting Market’s Future CAGR of 12.95%: Key Drivers, Innovations, and Insights to 203... - WhaTech
3D Printing Medical Devices Market size is set to grow by USD 7.07 billion from 2024-2028, Increased demand for personalized or customized medical devices boost the market, Technavio - The Malaysian Reserve
Organovo (NASDAQ:ONVO) Now Covered by StockNews.com - Defense World
Organovo Holdings hits 52-week low, trading at 0.55 USD - Investing.com
Organovo Holdings hits 52-week low, trading at 0.55 USD By Investing.com - Investing.com Nigeria
Organovo Holdings Inc Stock (ONVO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.89%
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):